Kathryn Reed

Momentum Stocks in Focus: USG Corporation (USG), LogMeIn, Inc. (LOGM), Radius Health, Inc. (RDUS)

USG Corporation (USG) failed to extend gains with the stock declining -0.18% or $-0.06 to close the day at $33.35 on light trading volume of 1.52M shares, compared to its three month average trading volume of 1.66M. The Chicago Illinois 60661 based company has been outperforming the general building materials group over the past 52 weeks, with the stock gaining 63.72%, compared to the industry which has advanced 43.04% over the same period. With RSI of 77.41, the stock should still continue to rise and get closer to its one year target estimate of $32.56, making it a hold for now.

USG Corporation, through its subsidiaries, manufactures and sells building materials worldwide. The company’s Gypsum segment manufactures and markets gypsum and related products to construct walls, ceilings, roofs, and floors of residential, commercial, and institutional buildings, as well as for various industrial applications. This segment offers gypsum panels, as well as joint compounds, corner beads, joint tapes, and plasters for wallboard joints finishing under the Sheetrock brand; cement board under the Durock brand; backerboard that includes abuse-resistant interior wall panels, tile backer boards, and flooring underlayments under the Fiberock brand; poured gypsum flooring systems under the Levelrock brand; roof boards under the Securock brand; and air-water barrier system and industrial gypsum under the ExoAir 430 brand. It also provides construction plaster products under the Red Top, Imperial, Diamond, and Supremo brands; and gypsum-based products for agricultural and industrial customers. The company’s Ceilings segment manufactures and markets interior systems products, including ceiling tiles under the Radar, Eclipse, Mars, and Halcyon brands; and ceiling grids under the Donn, DX, Fineline, Centricitee, Identitee DXI, Curvatura, and Compasso brands. Its USG Boral Building Products segment manufactures, distributes, and sells various building products, mines raw gypsum, and sells natural and synthetic gypsum. This segment offers plasterboards under the USG Boral Sheetrock brand; and ceiling suspension systems under the USG Boral NextGen, Elephant, Jayaboard, Durock, and Donn DX brands, as well as mineral fiber ceiling tiles, steel grids, and joint compounds for wall, ceiling, floor lining, and exterior systems. The company distributes its products through building material dealers, home improvement centers and other retailers, specialty wallboard distributors, and contractors. USG Corporation was founded in 1901 and is headquartered in Chicago, Illinois.

LogMeIn, Inc. (LOGM) grew with the stock adding 1.32% or $1.25 to close at $95.6 on light trading volume of 1.52M compared its three months average trading volume of 746.06K. The Boston Massachusetts 02210 based company operating under the Application Software industry has been trending up for the last 52 weeks, with the shares price now 95.1% up for the period and down by -0.49% so far this year. With price target of $113.38 and a 123.87% rebound from 52-week low, LogMeIn, Inc. has plenty of upside potential, making it a hold with a view buy.

LogMeIn, Inc. provides cloud-based services for individuals and businesses to securely connect to their workplace, colleagues, and customers. Its services include join.me, join.me pro, and join.me enterprise that are browser-based online meeting and screen sharing services; Cubby Basic, Cubby Pro, and Cubby Enterprise that are cloud-based file syncing, storage, and sharing services; and LogMeIn Pro, a remote access service. The company also provides support services, including LogMeIn Rescue, Rescue Lens, and LogMeIn Rescue+Mobile, which are Web-based remote support and customer care services offering remote support through the Internet; and BoldChat, a Web-based live chat service that helps customer service staff to directly engage and provide assistance to visitors to their organization’s Website. In addition, it offers IT management services, such as LogMeIn Central, a Web-based management console; Meldium, a password and identity management product to manage, store, and share login credentials; and AppGuru, an application management product, as well as connected products comprising Xively, a platform, which provides the infrastructure services to help businesses. Further, the company provides RemotelyAnywhere, a LAN-based systems administration product used to manage personal computers and servers from within the IT system of an enterprise; LogMeIn Backup, a service that subscribers install on two or more computers to create a backup network; LogMeIn Hamachi, a hosted virtual private network service; and LogMeIn for iOS services. It serves SMBs, IT service providers, mobile carriers, customer service centers, original equipment manufacturers, enterprise customers, and consumers. The company was formerly known as 3am Labs, Inc. and changed its name to LogMeIn, Inc. in March 2006. LogMeIn, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.

Radius Health, Inc. (RDUS) continued its upward trend with the stock climbing 6.78% or $3.05 to close the day at $48.06 on lower than average trading volume of 1.51M shares, compared to its three month average trading volume of 741.38K. The Waltham Massachusetts 02451 based company has been outperforming the biotechnology companies by -11.4862% for last three months and its recent losses have trimmed gains to 26.37% YTD, versus the biotechnology industry which is up 0.44% for the same period. The RSI of 64.61 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Radius Health, Inc., a biopharmaceutical company, develops and sells therapeutics in the areas of osteoporosis, oncology, and endocrine diseases primarily in the United States. Its product candidates include Abaloparatide-SC, a novel synthetic peptide analog of parathyroid hormone-related protein, which has been completed Phase III clinical development for the treatment of patients with postmenopausal osteoporosis; and Abaloparatide-TD, a transdermal patch that has been completed Phase II clinical trial, which is used as a short wear-time transdermal patch. The company is also involved in developing RAD1901, a selective estrogen receptor down-regulator/degrader, which is in Phase I clinical trial for the treatment of metastatic breast cancer and other estrogen receptor mediated oncology applications, as well as in Phase IIb clinical trial for the treatment of postmenopausal vasomotor symptoms; and RAD140, a nonsteroidal selective androgen receptor modulator that is in preclinical stage for the treatment of breast cancer or other conditions. It has collaborations and license agreements with Nordic Bioscience Clinical Development VII A/S; 3M; Ipsen Pharma SAS; Eisai Co. Ltd.; and Lonza Group Ltd., as well as clinical collaboration with Novartis Pharmaceuticals. Radius Health, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

 

Trader’s Round Up: EnteroMedics Inc. (ETRM), Lamb Weston Holdings, Inc. (LW), Bill Barrett Corporation (BBG)

EnteroMedics Inc. (ETRM) grew with the stock adding 2.55% or $0.19 to close at $7.64 on light trading volume of 1.39M compared its three months average trading volume of 11.98M. The St. Paul Minnesota 55113 based company operating under the Medical Appliances & Equipment industry has been trending up for the last 52 weeks, with the shares price now 564.35% up for the period and up by 282% so far this year. With price target of $140 and a 19000% rebound from 52-week low, EnteroMedics Inc. has plenty of upside potential, making it a hold with a view buy.

EnteroMedics Inc., a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The company develops the Maestro Rechargeable System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It has collaboration with Mayo Clinic for the development and testing of products for the treatment of obesity. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003. EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Lamb Weston Holdings, Inc. (LW) dropped $-0.02 to close the day at a new closing price of $39.63, a -0.05% decrease in value from its previous closing price that moved the stock 34.48% above its 52 week low of $29.62. A total of 1.39M shares exchanged hands during the day compared with its three month average trading volume of 1.95M. The stock, which fluctuated between $39.2 and $39.75 during the day, currently situated -0.43% below its 52 week high. The stock is up by 7.98% in the past one month and down by 0% over the past three months. With a one year target estimate of $40.5 and RSI of 73.81, the stock still has upside potential, making it a sell for now.

Lamb Weston Holdings, Inc. produces and markets value-added frozen potato products worldwide. It operates through four segments: Global, Foodservice, Retail, and Other. The company offers frozen potatoes, sweet potatoes, and appetizers under the Lamb Weston brand name, as well as various customer labels. It serves retail and foodservice customers; grocery, mass, club, and specialty retailers; and businesses, independent restaurants, regional chain restaurants, and convenience stores, as well as primary, secondary, and post-secondary educational institutions. The company was founded in 1950 and is based in Eagle, Idaho.

Bill Barrett Corporation (BBG) shares were up in last trading by 0.17% to $5.97. It experienced lighter than average volume on day. The stock increased in value by almost 1.7% over the past week and fell -17.77% in the past month. It is currently trading -14.66% below its 50 day moving average and -8.18% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -36.35% decrease in value from its one year high of $9.38. The RSI indicator value of 36.86, lead us to believe that it is a hold for now.

Bill Barrett Corporation, an independent energy company, acquires, explores for, and develops oil and natural gas resources in the United States. It primarily holds interests in the Denver-Julesburg basin and the Uinta oil program in the Uinta Basin in the Rocky Mountain region of the United States. The company was founded in 2002 and is headquartered in Denver, Colorado.

 

Trader Alert: Time Warner Inc. (TWX), Entergy Corporation (ETR), Altria Group, Inc. (MO)

Time Warner Inc. (TWX) grew with the stock adding 0.33% or $0.32 to close at $96.39 on active trading volume of 4.24M compared its three months average trading volume of 4.18M. The New York New York 10019 based company operating under the Entertainment – Diversified industry has been trending up for the last 52 weeks, with the shares price now 55.42% up for the period and down by -0.15% so far this year. With price target of $105.13 and a 58.22% rebound from 52-week low, Time Warner Inc. has plenty of upside potential, making it a hold with a view buy.

Time Warner Inc. operates as a media and entertainment company in the United States and internationally. It operates through three segments: Turner, Home Box Office, and Warner Bros. The Turner segment owns and operates a portfolio of cable television networks and related properties that offer entertainment, sports, kids, and news programming on television and digital platforms for consumers. It operates approximately 180 channels in 200 countries. The Turner segment’s networks and related properties include TNT, TBS, Adult Swim, truTV, Turner Classic Movies, Turner Sports, Cartoon Network, Boomerang, CNN, and HLN; and digital media properties comprise bleacherreport.com, NBA.com, NBA Mobile, NCAA.com, PGA.com, tntdrama.com, TBS.com, adultswim.com, and cartoonnetwork.com. It also licenses original programming to subscription-video-on-demand (SVOD) services and other over-the-top services, and its brands and characters for consumer products other business ventures. This segment serves cable system operators, satellite service distributors, telephone companies, and other distributors. The Home Box Office segment provides premium pay and basic tier television services comprising HBO and Cinemax; sells its original programming through physical and digital formats; and licenses home entertainment and content to international television networks and SVOD services. As of December 31, 2015, this segment had 49 million domestic subscribers. The Warner Bros. segment produces, distributes, and licenses television programming and feature films; distributes digital and physical home entertainment products; and produces and distributes videogames, as well as licenses consumer products and brands. The company was formerly known as AOL Time Warner, Inc. and changed its name to Time Warner Inc. in 2003. Time Warner Inc. was founded in 1985 and is headquartered in New York, New York.

Entergy Corporation (ETR) dropped $-1.17 to close the day at a new closing price of $70.79, a -1.63% decrease in value from its previous closing price that moved the stock 7.42% above its 52 week low of $66.71. A total of 1.48M shares exchanged hands during the day compared with its three month average trading volume of 1.37M. The stock, which fluctuated between $70.58 and $71.81 during the day, currently situated -11.35% below its 52 week high. The stock is up by 0.11% in the past one month and up by 6.3% over the past three months. With a one year target estimate of $73.5 and RSI of 50.22, the stock still has upside potential, making it a hold for now.

Entergy Corporation, together with its subsidiaries, engages in the generation and distribution of electricity in the United States. It operates in two segments, Utility and Entergy Wholesale Commodities. The Utility segment generates, transmits, distributes, and sells electric power in portions of Arkansas, Mississippi, Texas, and Louisiana, including the City of New Orleans; and distributes natural gas. The Entergy Wholesale Commodities segment is engaged in the ownership, operation, and decommissioning of nuclear power plants located in the northern United States; sells the electric power to wholesale customers; offers services to other nuclear power plant owners; and owns interests in non-nuclear power plants that sell the electric power to wholesale customers. This segment sells energy to retail power providers, utilities, electric power co-operatives, power trading organizations, and other power generation companies. It generates electricity through gas/oil, nuclear, coal, wind, and hydro power. The company’s power plants have approximately 30,000 megawatts (MW) of aggregate electric generating capacity, including approximately 10,000 MW of nuclear-fueled capacity. It delivers electricity to 2.8 million utility customers in Arkansas, Louisiana, Mississippi, and Texas. The company was founded in 1989 and is based in New Orleans, Louisiana.

Altria Group, Inc. (MO) shares were down in last trading by -0.22% to $71.88. It experienced lighter than average volume on day. The stock decreased in value by almost -0.44% over the past week and grew 6.36% in the past month. It is currently trading 5.21% above its 50 day moving average and 10.37% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -0.98% decrease in value from its one year high of $72.59. The RSI indicator value of 71.81, lead us to believe that it may reverse gains in the near term.

Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, smokeless products, and wine in the United States. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen and Skoal, Red Seal and Husky, and Marlboro Snus brand names. The company also produces and sells varietal and blended table wines, and sparkling wines under the Chateau Ste. Michelle, Columbia Crest, and 14 Hands names; and imports and markets Antinori, Torres, and Villa Maria Estate wines, as well as Champagne Nicolas Feuillatte in the United States. In addition, it provides finance leasing services primarily in aircraft, railcar, electric power, real estate, and manufacturing industries. The company sells its tobacco products primarily to wholesalers, including distributors; large retail organizations, such as chain stores; and the armed services. Altria Group, Inc. was founded in 1919 and is headquartered in Richmond, Virginia.

 

Momentum Stocks in Focus: Great Basin Scientific, Inc. (GBSN), GigPeak, Inc. (GIG), ZAIS Group Holdings, Inc. (ZAIS)

Great Basin Scientific, Inc. (GBSN) managed to rebound with the stock declining -12.5% or $0 to close the day at $0 on active trading volume of 111.86M shares, compared to its three month average trading volume of 107.35M. The Salt Lake City Utah 84111 based company has been underperforming the medical laboratories & research group over the past 52 weeks, with the stock losing 0%, compared to the industry which has advanced 27.16% over the same period. With RSI of 0, the stock should still continue to rise and get closer to its one year target estimate of $1575840, making it a hold for now.

Great Basin Scientific, Inc., a molecular diagnostic testing company, develops and commercializes molecular diagnostic systems that are designed to test hospital-acquired infections. The company’s platform provides C. diff test, a rapid medical diagnostic test for the detection of C. diff, a gram-positive bacteria that causes severe diarrhea and other intestinal disorders. It also provides Group B streptococcus test, which is used to detect Group B streptococcus from an anal/vaginal swab of a pregnant woman. The company’s assays in clinical trials include Staphylococcus identification and resistance blood infection panel that is designed to identify species of staphylococcus infections, detect the mecA gene that confers drug resistance directly from positive blood cultures, and provide information on the antibiotic resistance profile of the bacteria; and Shiga toxin producing Escherichia coli (E. coli) test that identifies shiga toxin produced by E. coli. Its assays under development include Staphyloccocus aureus (SA) pre-surgical nasal screen, a rapid test for the presence of SA in the nasal passages of a pre-surgical patient; Stool bacterial pathogenic panel, which is designed to detect the causes of food poisoning; Candida blood infections panel that is designed to identify the five species of Candida directly from positive blood cultures; Pertussis test for contagious respiratory disease caused by the bacterium Bordetella pertussis; and CT/NG test for chlamydia tracomatis/neisseria gonorrhoeae. The company sells its diagnostic tests through a direct sales force in the United States, as well as through distributors in the European Union and New Zealand. The company was formerly known as Diagnostic Micro Arrays, Inc. and changed its name to Great Basin Scientific, Inc. in April 2006. Great Basin Scientific, Inc. is headquartered in Salt Lake City, Utah.

GigPeak, Inc. (GIG) grew with the stock adding 12.55% or $0.34 to close at $3.05 on light trading volume of 35.89M compared its three months average trading volume of 489.78K. The San Jose California 95134 based company operating under the Semiconductor Equipment & Materials industry has been trending up for the last 52 weeks, with the shares price now 32.03% up for the period and up by 21.03% so far this year. With price target of $3.65 and a 87.12% rebound from 52-week low, GigPeak, Inc. has plenty of upside potential, making it a hold with a view buy.

GigPeak, Inc. provides semiconductor ICs and software solutions for high-speed connectivity and video compression over the network and the cloud. The company designs, develops, and supplies analog, digital, and mixed signal components to enable high speed information streaming over the telecom networks, datacom infrastructure, and consumer electronics links. It offers a portfolio of modulator drivers and transimpedance amplifiers, and driver solutions to interface with the Lithium Niobate and Indium Phosphide optical modulators; optical, analog, and mixed signal solutions for high-speed data transmission products; wireless RF and MMIC products, including integrated broadband transceivers, transmitters, receivers, amplifiers, power detectors, and delay elements for microwave, millimeter- wave, and GNSS applications; and structured ASIC products to low geometry high end standard cells. The company’s industrial product line provides various digital and mixed-signal application specific integrated circuit solutions for industrial applications used in the military, avionics, medical, and communications markets. It markets and sells its products in Asia, North America, Europe, and internationally through direct sales force, distributors, and sales representatives. The company was formerly known as GigOptix, Inc. and changed its name to GigPeak, Inc. in April 2016. GigPeak, Inc. was founded in 2007 and is headquartered in San Jose, California.

ZAIS Group Holdings, Inc. (ZAIS) continued its upward trend with the stock climbing 110.73% or $2.27 to close the day at $4.32 on higher than average trading volume of 25.92M shares, compared to its three month average trading volume of 111.36K. The Red Bank New Jersey 07701 based company has been outperforming the asset management companies by 149.6075% for last three months and its recent gains have pushed the stock slightly up 193.88% YTD, versus the asset management industry which is up 5.25% for the same period. The RSI of 86.47 indicates the stock is overbought at the current levels, sell for now.

ZAIS Group Holdings, Inc., an investment management company, focuses on investments in specialized credit strategies. The company manages assets across mortgage-related specialized credit strategies, including residential whole loans, residential mortgage backed securities, asset backed securities, and commercial mortgage backed securities; and corporate-credit, including collateralized loan obligations, collateralized bond obligations, collateralized synthetic obligations, credit default swaps, high yield bonds, and leveraged loans. It also provides solutions to investors in structured credit. ZAIS Group Holdings, Inc. has operations in the United States, London, and Shanghai. The company was founded in 1997 and is based in Red Bank, New Jersey.

 

Stocks In Queue: CEL-SCI Corporation (CVM), Uranium Energy Corp. (UEC), InterCloud Systems, Inc. (ICLD)

CEL-SCI Corporation (CVM) fell -13.27% during last trading as the stock lost $-0.02 to finish the day at $0.13 with about 4.58M shares changing hands, compared to its three month average trading volume of 2.69M. The $24.04M market cap company, which fluctuated between $0.125 and $0.147 during the day, currently situated 116.83% above its 52 week low of $0.06 and -80.29% away from its one year high of $0.66. The RSI of 54.37 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

Uranium Energy Corp. (UEC) gained $0.08 to close the day at a new closing price of $1.84, a 4.55% increase in value from its previous closing price that moved the stock 166.67% above its 52 week low of $0.69. A total of 4.48M shares exchanged hands during the day compared with its three month average trading volume of 2.15M. The stock, which fluctuated between $1.75 and $1.92 during the day, currently situated 1.1% above its 52 week high. The stock is up by 9.52% in the past one month and up by 100% over the past three months. With a one year target estimate of $2.81 and RSI of 67.62, the stock still has upside potential, making it a hold for now.

Uranium Energy Corp. engages in the exploration, pre-extraction, extraction, and processing of uranium concentrates on projects located in the United States and the Republic of Paraguay. As of July 31, 2016, it had mineral rights in uranium projects located in the states of Arizona, Colorado, New Mexico, Texas, and Wyoming, as well as in the Republic of Paraguay. The company was formerly known as Carlin Gold Inc. and changed its name to Uranium Energy Corp. in January 2005. Uranium Energy Corp. was incorporated in 2003 and is based in Corpus Christi, Texas.

InterCloud Systems, Inc. (ICLD) had a light trading with around 4.47M shares changing hands compared to its three month average trading volume of 7.13M. The stock traded between $0.018 and $0.02 before closing at the price of $0.02 with -2.06% change on the day. The Shrewsbury New Jersey 07702 based company is currently trading 18.75% above its 52 week low of $0.016 and -81.65% below its 52 week high of $1.15. Both the RSI indicator and target price of 40.71 and $6 respectively, lead us to believe that it should be put on hold over the coming weeks.

InterCloud Systems, Inc. provides end-to-end IT and network solutions to the telecommunications service provider and corporate enterprise markets through cloud platforms and professional services in the United States and internationally. It operates through four segments: Applications and Infrastructure, Professional Services, Managed Services, and Cloud Services. The company offers various services, including platform as a service, infrastructure as a service, database as a service, and software as a service; and network management, 24x7x365 monitoring, security monitoring, and storage and backup services. It also provides software-defined networking (SDN) training, SDN software development and integration, virtualized network functions validation in a multi-vendor environment, unified communications, interactive voice response, and session initiation protocol based call centers, as well as structured cabling and other field installations. In addition, the company designs, engineers, installs, and maintains various types of Wi-Fi and wide-area, distributed antenna system, and small cell distribution networks for incumbent local exchange carriers, telecommunications original equipment manufacturers (OEMs), cable broadband multiple system operators, and enterprise customers, as well as designs, installs, and maintains hardware solutions for the OEMs that support voice, data, and optical networks. Further, it provides consulting and professional staffing solutions to the service-provider and enterprise market in support of IT and next-generation networks comprising project management, network implementation, network installation, network upgrades, rebuilds, maintenance, and consulting services. Additionally, the company’s engineering, design, installation, and maintenance services support the build-out and operation of enterprise, fiber optic, Ethernet, and wireless networks. InterCloud Systems, Inc. was founded in 2006 and is based in Shrewsbury, New Jersey.

 

Traders Watch list: United Technologies Corporation (UTX), Dollar General Corporation (DG), Norwegian Cruise Line Holdings Ltd. (NCLH)

United Technologies Corporation (UTX) saw its value decrease by -0.4% as the stock dropped $-0.45 to finish the day at a closing price of $111.57. The stock was lighter in trading and has fluctuated between $86.64-$112.83 per share for the past year. The shares, which traded within a range of $111.45 to $112.32 during the day, are up by 3.12% in the past three months and up by 2.96% over the past six months. It is currently trading 1.18% above its 20 day moving average and 1.33% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $117.93 a share over the next twelve months. The current relative strength index (RSI) reading is 56.85.The technical indicator lead us to believe there will be no major movement any time soon, hold.

United Technologies Corporation provides technology products and services to building systems and aerospace industries worldwide. Its Otis segment designs, manufactures, sells, and installs passenger and freight elevators, escalators, and moving walkways; and offers modernization products to upgrade elevators and escalators, as well as maintenance and repair services. The company’s UTC Climate, Controls & Security segment provides heating, ventilating, air conditioning, and refrigeration solutions, such as controls for residential, commercial, industrial, and transportation applications. This segment offers electronic security products, including intruder alarms, access control systems, and video surveillance systems; fire safety products; and design, installation, systems integration, repair, maintenance, monitoring, and inspection services. Its Pratt & Whitney segment supplies aircraft engines for commercial, military, business jet, and general aviation markets; and provides aftermarket maintenance, repair, and overhaul, as well as fleet management services. The company’s UTC Aerospace Systems segment provides electric power generation, power management, and distribution systems; air data and aircraft sensing systems; engine control, intelligence, surveillance, and reconnaissance systems; engine components; environmental control systems; fire and ice detection, and protection systems; propeller systems; engine nacelle systems; aircraft lighting and seating, and cargo systems; actuation and landing systems; space products and subsystems; and aftermarket services. United Technologies Corporation offers its services through manufacturers’ representatives, distributors, wholesalers, dealers, retail outlets, and sales representatives, as well as directly to customers. United Technologies Corporation was founded in 1934 and is headquartered in Farmington, Connecticut.

Dollar General Corporation (DG) shares were up in last trading by 1.47% to $77.14. It experienced higher than average volume on day. The stock increased in value by almost 5.96% over the past week and grew 5.54% in the past month. It is currently trading 3.85% above its 50 day moving average and -3.11% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -19.83% decrease in value from its one year high of $96.88. The RSI indicator value of 61.24, lead us to believe that it is a hold for now.

Dollar General Corporation, a discount retailer, provides various merchandise products in the southern, southwestern, midwestern, and eastern United States. The company offers consumable products, including paper and cleaning products comprising paper towels, bath tissues, paper dinnerware, trash and storage bags, and laundry and other home cleaning supplies; packaged food products, such as cereals, canned soups and vegetables, condiments, spices, sugar, and flour; perishables consisting of milk, eggs, bread, frozen meals, beer, and wine; snacks that comprise candies, cookies, crackers, salty snacks, and carbonated beverages; health and beauty products, such as over-the-counter medicines, as well as soap, body wash, shampoo, dental hygiene, and foot care products; pet products, which include pet supplies and pet food; and tobacco products. It also provides seasonal products, including decorations, toys, batteries, small electronics, greeting cards, stationery products, prepaid phones and accessories, gardening supplies, hardware products, and automotive and home office supplies; and home products consisting of kitchen supplies, cookware, small appliances, light bulbs, storage containers, frames, candles, craft supplies and kitchen products, beds, and bath soft goods. In addition, the company offers apparel for infants, toddlers, girls, boys, women, and men, as well as socks, underwear, disposable diapers, shoes, and accessories. As of October 28, 2016, it operated 13,205 stores located in 43 states. The company was formerly known as J.L. Turner & Son, Inc. and changed its name to Dollar General Corporation in 1968. Dollar General Corporation was founded in 1939 and is based in Goodlettsville, Tennessee.

Norwegian Cruise Line Holdings Ltd. (NCLH) traded within a range of $47.58 to $47.97 after opening the day at $47.82. The company has seen its stock increase in value by 12.32% so far this year. The stock was down close to -0.21% on light volume in last trading session and closed at $47.77 per share. After the recent fall, the stock is currently holding -14.07% below its 52 week high of $55.59 and 39.84% above its 12-month low of $34.16. The shares are up by over 24.34% in the last three months, and the RSI indicator value of 57.24 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Norwegian Cruise Line Holdings Ltd. operates as a cruise line company that offers various itineraries. It provides cruises ranging from 1 day to 180 days itineraries to approximately 510 destinations worldwide. The company offers its products through independent travel agents, wholesalers, and tour operators. It operates 24 ships under the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands with approximately 46,500 Berths. The company was founded in 1966 and is headquartered in Miami, Florida.

 

Stocks Trend Analysis: Macy’s, Inc. (M), Wal-Mart Stores, Inc. (WMT), The Bank of New York Mellon Corporation (BK)

Macy’s, Inc. (M) continued its upward trend with the stock climbing 0.31% or $0.1 to close the day at $32.68 on light trading volume of 7.54M shares, compared to its three month average trading volume of 8.11M. The Cincinnati Ohio 45202 based company has been underperforming the department stores group over the past 52 weeks, with the stock losing -15.98%, compared to the industry which has advanced 2.77% over the same period. With RSI of 53.32, the stock should still continue to rise and get closer to its one year target estimate of $35.6, making it a hold for now.

Macy’s, Inc., together with its subsidiaries, operates stores, Websites, and mobile applications. Its stores and Websites sell a range of merchandise, including apparel and accessories for men, women, and children; cosmetics; home furnishings; and other consumer goods. The company also operates stores that offer a range of women’s, men’s, and children’s apparel; shoes; fashion accessories; housewares; home textiles; intimate apparel; and jewelry. As of January 4, 2017, it operated approximately 880 stores in the United States, the District of Columbia, Guam, and Puerto Rico under the Macy’s, Bloomingdale’s, Bloomingdale’s Outlet, Macy’s Backstage, and Bluemercury brands, as well as Websites, including macys.com, bloomingdales.com, and bluemercury.com. In addition, it operates as a beauty products and spa retailer. The company was formerly known as Federated Department Stores, Inc. and changed its name to Macy’s, Inc. in June 2007. Macy’s, Inc. was founded in 1830 and is based in Cincinnati, Ohio.

Wal-Mart Stores, Inc. (WMT) grew with the stock adding 1.31% or $0.89 to close at $68.66 on light trading volume of 8.46M compared its three months average trading volume of 8.76M. The Bentonville Arkansas 72716 based company operating under the Discount, Variety Stores industry has been trending up for the last 52 weeks, with the shares price now 7.21% up for the period and down by -0.67% so far this year. With price target of $74.04 and a 13.32% rebound from 52-week low, Wal-Mart Stores, Inc. has plenty of upside potential, making it a hold with a view buy.

Wal-Mart Stores, Inc. operates retail stores in various formats worldwide. It operates through three segments: Walmart U.S., Walmart International, and Sam’s Club. The company operates discount stores, supermarkets, supercenters, hypermarkets, warehouse clubs, cash and carry stores, home improvement stores, specialty electronics stores, apparel stores, drug stores, convenience stores, and membership-only warehouse clubs; and retail Websites, such as walmart.com and samsclub.com. It offers grocery products, including meat, produce, natural and organics, deli and bakery, dairy, frozen foods, alcoholic and nonalcoholic beverages, floral and dry grocery, as well as consumables, such as health and beauty aids, baby products, household chemicals, paper goods, and pet supplies; and health and wellness products, which include pharmacy, optical services, clinical services, over-the-counter drugs, and other medical products. The company also provides electronics, toys, cameras and supplies, photo processing services, cellular phones, cellular service plan contracts and prepaid service, movies, music, video games, and books; stationery, automotive, hardware and paint, and sporting goods, as well as fabrics, crafts, and seasonal merchandise; apparel for women, girls, men, boys, and infants, as well as shoes, jewelry, and accessories; and home furnishings, housewares and small appliances, bedding, home decor, outdoor living, and horticulture products. The company also provides fuel and financial services and related products, including money orders, prepaid cards, wire transfers, money transfers, check cashing, and bill payment. In addition, it offers brand name merchandise, including hardgoods, softgoods, and selected private-label items, such as Member’s Mark. As of June 20, 2016, it operated 11,527 stores under 63 banners in 28 countries and e-commerce Websites in 11 countries. Wal-Mart Stores, Inc. was founded in 1945 and is headquartered in Bentonville, Arkansas.

The Bank of New York Mellon Corporation (BK) continued its upward trend with the stock climbing 1.52% or $0.7 to close the day at $46.82 on lower than average trading volume of 4.71M shares, compared to its three month average trading volume of 6.02M. The New York New York 10286 based company has been outperforming the asset management companies by 0.5175% for last three months and its recent gains have offset losses to -0.76% YTD, versus the asset management industry which is up 5.25% for the same period. The RSI of 60.01 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

The Bank of New York Mellon Corporation, an investment company, provides financial products and services to institutions, corporations, and high net worth individuals in the United States and internationally. It operates through two segments, Investment Management and Investment Services. The company offers investment management; trust and custody; foreign exchange; fund administration; global collateral services; securities lending; depositary receipts; corporate trust; global payment/cash management; banking services; and clearing services. It also provides mutual funds, separate accounts, wealth management and private banking services; and broker-dealer services, registered investment advisory services, prime brokerage services, and working capital solutions. In addition, the company is involved in credit-related activities, business exits, leasing operations, and corporate treasury activities; and the provision of global markets and institutional banking services. The Bank of New York Mellon Corporation was founded in 1784 and is headquartered in New York, New York.

 

Three Movers to Watch for: MetLife, Inc. (MET), Mylan N.V. (MYL), Alexion Pharmaceuticals, Inc. (ALXN)

MetLife, Inc. (MET) grew with the stock adding 0.71% or $0.38 to close at $53.88 on light trading volume of 4.93M compared its three months average trading volume of 6M. The New York New York 10166 based company operating under the Life Insurance industry has been trending up for the last 52 weeks, with the shares price now 46.67% up for the period and up by 0.72% so far this year. With price target of $59.86 and a 52.77% rebound from 52-week low, MetLife, Inc. has plenty of upside potential, making it a hold with a view buy.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Mylan N.V. (MYL) gained $0.97 to close the day at a new closing price of $40.75, a 2.44% increase in value from its previous closing price that moved the stock 21.28% above its 52 week low of $33.6. A total of 5.5M shares exchanged hands during the day compared with its three month average trading volume of 5.03M. The stock, which fluctuated between $39.56 and $40.91 during the day, currently situated -19.15% below its 52 week high. The stock is up by 10.94% in the past one month and up by 7.43% over the past three months. With a one year target estimate of $49.84 and RSI of 69.18, the stock still has upside potential, making it a hold for now.

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, cream, or ointment forms, as well as active pharmaceutical ingredients (APIs). It is also involved in the development of APIs with non-infringing processes for internal use and to partner with manufacturers; and manufacture and sale of injectable products in antineoplastics, anti-infectives, anesthesia/pain management, and cardiovascular therapeutic areas. In addition, the company produces finished dosage form and oral solid dose products; and offers antiretroviral therapies to third parties. Further, it manufactures and sells branded specialty injectable and nebulized products comprising EpiPen Auto-Injector to treat severe allergic reactions; Perforomist Inhalation Solution, a formoterol fumarate inhalation solution for the maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disorder patients; and ULTIVA, an analgesic agent used during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. It sells generic pharmaceutical products to proprietary and ethical pharmaceutical wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies; and specialty pharmaceuticals to pharmaceutical wholesalers and distributors, pharmacies, and healthcare institutions. Mylan N.V. has a collaboration agreement with Momenta Pharmaceuticals, Inc. to develop, manufacture, and commercialize Momenta Pharmaceuticals, Inc.’s biosimilar candidates. The company was formerly known as New Moon B.V. Mylan N.V. was founded in 1961 and is based in Hertfordshire, the United Kingdom.

Alexion Pharmaceuticals, Inc. (ALXN) shares were up in last trading by 1.35% to $129.5. It experienced higher than average volume on day. The stock increased in value by almost 1.39% over the past week and fell -5.43% in the past month. It is currently trading 1.49% above its 50 day moving average and 0.36% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -20.06% decrease in value from its one year high of $162. The RSI indicator value of 53.53, lead us to believe that it is a hold for now.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia (HPP); and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. The company also conducts Phase IV clinical trials on Soliris for the treatment of PNH registry; Phase III clinical trials for the treatment of myasthenia gravis, neuromyelitis optica spectrum disorder, and delayed kidney transplant graft function; and Phase II clinical trials for antibody mediated rejection in presensitized renal transplant patients. It develops cPMP (ALXN 1101) that is in Phase II/III trial for treating metabolic disorders; and ALXN 1007, a novel humanized antibody in Phase II clinical trial for the treatment of anti-phospholipid syndrome and graft versus host disease. The company serves distributors, pharmacies, hospitals, hospital buying groups, and other health care providers, as well as governments and government agencies in the United States, Europe, the Asia Pacific, and internationally. Alexion Pharmaceuticals, Inc. has agreements with X-Chem Pharmaceuticals (X-Chem) to identify novel drug candidates from X-Chem’s proprietary drug discovery engine; Moderna Therapeutics, Inc. (Moderna) that provides the option to purchase drug products for clinical development commercialization of Moderna’s messenger RNA therapeutics to treat rare diseases; and Ensemble Therapeutics Corporation for the identification, development, and commercialization of therapeutic candidates based on specific drug targets. The company was founded in 1992 and is headquartered in New Haven, Connecticut.

 

Trader Alert: Newell Brands Inc. (NWL), The Mosaic Company (MOS), ONEOK, Inc. (OKE)

Newell Brands Inc. (NWL) grew with the stock adding 1% or $0.47 to close at $47.53 on light trading volume of 3.49M compared its three months average trading volume of 4.33M. The Atlanta Georgia 30328 based company operating under the Housewares & Accessories industry has been trending up for the last 52 weeks, with the shares price now 34.22% up for the period and up by 6.45% so far this year. With price target of $56.13 and a 38.69% rebound from 52-week low, Newell Brands Inc. has plenty of upside potential, making it a hold with a view buy.

Newell Brands Inc. designs, sources, and distributes consumer and commercial products worldwide. The company offers markers and highlighters, pens, and pencils; art products; activity-based adhesive and cutting products; fine writing instruments; and labeling solutions under the Sharpie, Paper Mate, Expo, Prismacolor, Mr.Sketch, Elmer’s, X-Acto, Parker, Waterman, and Dymo Office brands. It also provides indoor/outdoor organization, food storage, and home storage products; durable beverage containers; gourmet cookware, bakeware, and cutlery; and hair care accessories under the Rubbermaid, Contigo, Bubba, Calphalon, and Goody brands; and home fragrance products under the WoodWick Candle brand. In addition, the company offers hand and power tool accessories, industrial band saw blades, tools for HVAC systems, and industrial label makers and printers under Irwin, Lenox, Hilmor, and Dymo Industrial brands; cleaning and refuse products, hygiene systems, and material handling solutions under the Rubbermaid Commercial Products brand names; and infant and juvenile products, such as car seats, strollers, highchairs, and playards directly under the Graco, Baby Jogger, Aprica, and Teutonia brands. Further, it provides branded consumer products, consumables, and household staples under the Yankee Candle, Waddington, Ball, Diamond, First Alert, NUK, and Pine Mountain brands; kitchen appliances and home environment products under the Crock-Pot, FoodSaver, Holmes, Mr. Coffee, Oster, Rainbow, and Sunbeam brands; products for outdoor and outdoor-related activities under the Coleman, Jostens, Berkley, Shakespeare, Rawlings, Völkl, K2, and Marmot brands; and plastic products, including closures, contact lens packaging, medical disposables, plastic cutlery, and rigid packaging under the Jarden name. The company was formerly known as Newell Rubbermaid Inc. and changed its name to Newell Brands Inc. in April 2016. The company was founded in 1903 and is headquartered in Atlanta, Georgia.

The Mosaic Company (MOS) gained $0.27 to close the day at a new closing price of $34.02, a 0.8% increase in value from its previous closing price that moved the stock 59.59% above its 52 week low of $22.77. A total of 3.4M shares exchanged hands during the day compared with its three month average trading volume of 4.88M. The stock, which fluctuated between $33.41 and $34.03 during the day, currently situated -0.99% below its 52 week high. The stock is up by 8.86% in the past one month and up by 25.38% over the past three months. With a one year target estimate of $28.01 and RSI of 68.01, the stock still has upside potential, making it a hold for now.

The Mosaic Company, through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients primarily for the agricultural industry worldwide. The company operates through three segments: Phosphates, Potash, and International Distribution. It owns and operates mines, which produce concentrated phosphate crop nutrients, such as diammonium phosphate, monoammonium phosphate, and ammoniated phosphate products; and phosphate-based animal feed ingredients primarily under the Biofos and Nexfos brand names. The company also produces and sells potash for use in the manufacturing of mixed crop nutrients and animal feed ingredients, and for industrial use; and for use in the de-icing and as a water softener regenerant, as well as fluorosilicic acid for water fluoridation. In addition, it provides nitrogen-based crop nutrients and animal feed ingredients, and other ancillary services; and purchases and sells phosphates, potash, and nitrogen products. The company sells its products to wholesale distributors, retail chains, cooperatives, independent retailers, and national accounts. The Mosaic Company was founded in 2004 and is headquartered in Plymouth, Minnesota.

ONEOK, Inc. (OKE) shares were down in last trading by -0.13% to $54.95. It experienced higher than average volume on day. The stock increased in value by almost 1.07% over the past week and fell -1.32% in the past month. It is currently trading -2.15% below its 50 day moving average and 14.02% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -7.34% decrease in value from its one year high of $59.47. The RSI indicator value of 47.16, lead us to believe that it is a hold for now.

ONEOK, Inc., through its general partner interests in ONEOK Partners, L.P., engages in the gathering, processing, storage, and transportation of natural gas in the United States. It operates through the Natural Gas Gathering and Processing, the Natural Gas Liquids, and the Natural Gas Pipelines segments. The company gathers, treats, fractionates, stores, and transports natural gas liquids (NGL), as well as owns natural gas liquids gathering and distribution pipelines, natural gas liquids distribution and refined petroleum products pipelines, and terminal and storage facilities; and operates interstate and intrastate regulated natural gas transmission pipelines and natural gas storage facilities, as well as stores, markets, and distributes NGL products to petrochemical manufacturers, heating fuel users, ethanol producers, refineries, exporters, and propane distributors. It also owns and operates a parking garage in downtown Tulsa, Oklahoma; and leases excess office space to others. ONEOK, Inc. was founded in 1906 and is headquartered in Tulsa, Oklahoma.

 

Stocks Under Consideration: DENTSPLY SIRONA Inc. (XRAY), Eli Lilly and Company (LLY), Microsoft Corporation (MSFT)

DENTSPLY SIRONA Inc. (XRAY) grew with the stock adding 1.53% or $0.9 to close at $59.74 on active trading volume of 2.23M compared its three months average trading volume of 1.57M. The York Pennsylvania 17405 based company operating under the Medical Instruments & Supplies industry has been trending up for the last 52 weeks, with the shares price now 7.81% up for the period and up by 3.48% so far this year. With price target of $66.5 and a 11.1% rebound from 52-week low, DENTSPLY SIRONA Inc. has plenty of upside potential, making it a hold with a view buy.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. It also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as computer aided design and machining ceramic systems, and porcelain furnaces. In addition, the company provides dental specialty products, which include endodontic instruments and materials, implants and related products, 3D digital scanning and treatment planning software, and dental and orthodontic appliances and accessories. Further, it offers consumable medical device products, such as urology catheters, various surgical products, medical drills, and other products. The company markets and sells its dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and medical products directly, as well as through distributors to urologists, urology nurses, and general practitioners. DENTSPLY International Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Eli Lilly and Company (LLY) had a light trading with around 3.31M shares changing hands compared to its three month average trading volume of 6.11M. The stock traded between $77.25 and $78.83 before closing at the price of $78.81 with 1.34% change on the day. The Indianapolis Indiana 46285 based company is currently trading 23.62% above its 52 week low of $64.18 and -4.08% below its 52 week high of $83.79. Both the RSI indicator and target price of  and $86.35 respectively, lead us to believe that it could rise over the coming weeks.

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. It also provides neuroscience products for the treatment of depressive disorders, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorders; depressive, obsessive-compulsive, bulimia nervosa, and panic disorders; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains. In addition, the company offers products for the treatment of non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products. Further, it provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry; and chewable tablets that kill fleas and prevent flea infestations, heartworm diseases, roundworm diseases, hookworm diseases, and whipworm diseases. Additionally, the company offers products to treat chronic manifestations of atopic dermatitis and congestive heart failure in dogs; and chronic allergic dermatitis and kidney diseases in cats. It has a clinical collaboration agreement with Athenex, Inc.; and a research agreement with AstraZeneca for the development of clinical candidate MEDI1814 as a disease-modifying treatment for Alzheimer’s disease. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Microsoft Corporation (MSFT) saw its value decrease by -0.23% as the stock dropped $-0.15 to finish the day at a closing price of $64.57. The stock was lighter in trading and has fluctuated between $48.04-$65.91 per share for the past year. The shares, which traded within a range of $64.02 to $64.72 during the day, are up by 10.14% in the past three months and up by 12.55% over the past six months. It is currently trading 1.39% above its 20 day moving average and 2.75% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $68.97 a share over the next twelve months. The current relative strength index (RSI) reading is 59.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Microsoft Corporation, a technology company, develops, licenses, and supports software products, services, and devices worldwide. The company’s Productivity and Business Processes segment offers Office 365 commercial products and services for businesses, including Office, Exchange, SharePoint, and Skype, as well as related Client Access Licenses (CALs); Office 365 consumer services, such as Skype, Outlook.com, and OneDrive; Dynamics business solutions, such as financial management, customer relationship management, supply chain management, and analytics applications for small and mid-size businesses, large organizations, and divisions of enterprises; and LinkedIn online professional network. Its Intelligent Cloud segment licenses server products and cloud services, such as SQL Server, Windows Server, Visual Studio, System Center, and related CALs, as well as Azure, a cloud platform with computing, networking, storage, database, and management services; and enterprise services, such as Premier Support and Microsoft Consulting that assist in developing, deploying, and managing Microsoft server and desktop solutions, as well as provide training and certification to developers and IT professionals on Microsoft products. The company’s More Personal Computing segment comprises Windows OEM, volume, and other non-volume licensing of the Windows operating system, as well as patent licensing, Windows Embedded, MSN display advertising, and Windows Phone licensing system; devices, including Microsoft Surface, phones, and PC accessories; and search advertising, including Bing and Bing Ads. This segment also provides gaming platforms, including Xbox hardware, Xbox Live, video games, and third-party video games. The company markets and distributes its products through original equipment manufacturers (OEM), distributors, and resellers, as well as through online and Microsoft retail stores. Microsoft Corporation was founded in 1975 and is headquartered in Redmond, Washington.